# Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement

> **NCT01294592** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 742 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Dutasteride plus tamsulosin
- **DRUG:** tamsulosin

## Key facts

- **NCT ID:** NCT01294592
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-22
- **Primary completion:** 2013-10-17
- **Final completion:** 2013-10-17
- **Target enrollment:** 742 (ACTUAL)
- **Last updated:** 2018-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294592, "Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01294592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*